These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23424817)

  • 1. Challenges and facilitators of community clinical oncology program participation: a qualitative study.
    McAlearney AS; Reiter KL; Weiner BJ; Minasian L; Song PH
    J Healthc Manag; 2013; 58(1):29-44; discussion 45-6. PubMed ID: 23424817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.
    McAlearney AS; Song PH; Reiter KL
    Contemp Clin Trials; 2012 Nov; 33(6):1143-9. PubMed ID: 22925970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.
    Reiter KL; Song PH; Minasian L; Good M; Weiner BJ; McAlearney AS
    Cancer; 2012 Sep; 118(17):4253-61. PubMed ID: 22213241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
    Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
    Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing community-based provider participation in research: an empirical study.
    Teal R; Bergmire DM; Johnston M; Weiner BJ
    Implement Sci; 2012 May; 7():41. PubMed ID: 22568935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
    Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
    Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the predictors of innovation implementation in healthcare: a quantitative analysis of implementation effectiveness.
    Jacobs SR; Weiner BJ; Reeve BB; Hofmann DA; Christian M; Weinberger M
    BMC Health Serv Res; 2015 Jan; 15():6. PubMed ID: 25608564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
    Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
    Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
    Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
    J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience.
    Wieder R; Teal R; Saunders T; Weiner BJ
    J Oncol Pract; 2013 Mar; 9(2):e48-54. PubMed ID: 23814524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.
    Song PH; Reiter KL; Weiner BJ; Minasian L; McAlearney AS
    Health Care Manage Rev; 2013; 38(4):284-94. PubMed ID: 23044836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM; Hynes DM; Kaluzny AD
    J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.
    Tan HJ; Meyer AM; Kuo TM; Smith AB; Wheeler SB; Carpenter WR; Nielsen ME
    Cancer; 2015 Mar; 121(6):836-43. PubMed ID: 25410684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
    Jacobs SR; Weiner BJ; Minasian LM; Good MJ
    Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.
    Dimond EP; St Germain D; Nacpil LM; Zaren HA; Swanson SM; Minnick C; Carrigan A; Denicoff AM; Igo KE; Acoba JD; Gonzalez MM; McCaskill-Stevens W
    Clin Trials; 2015 Jun; 12(3):246-56. PubMed ID: 25691600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
    Weiner BJ; Jacobs SR; Minasian LM; Good MJ
    J Oncol Pract; 2012 Sep; 8(5):287-91. PubMed ID: 23277765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
    Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
    J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
    Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
    Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program.
    Zon RT
    Am Soc Clin Oncol Educ Book; 2014; ():e116-9. PubMed ID: 24857089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.